NCT02254226View on ClinicalTrials.gov

Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

January 31, 2005

Conditions
Healthy
Interventions
DRUG

Salmeterol Diskus low

DRUG

Salmeterol Diskus high

DRUG

Salmeterol MDI low

DRUG

Salmeterol MDI high

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02254226 - Pharmacokinetics of Salmeterol (Serevent®) After Inhalation With Metered Dose Inhaler (MDI) and Diskus® in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter